Funds with similar focus
|C Cube Angels||Mauritius, Port Louis, Port Louis|
|Fitalent||Community of Madrid, Madrid, Spain|
|lool ventures||Israel, Tel Aviv, Tel Aviv|
|Nova Ventures||Massachusetts, United States, Woburn|
|Ogden Capital||Atlanta, Georgia, United States|
|Polygon||Massachusetts, North Andover, United States|
|Rockspring||Cambridge, Cambridgeshire, United Kingdom|
|Zhongxin Shengye Keji||Beijing, China, Haidian|
|$180M||15 Apr 2022||Bangalore, Karnataka, India|
|$53M||14 Jul 2021||Los Angeles, California, United States|
|$9M||30 Apr 2020||Bengaluru, Karnataka, India|
|$4M||24 Oct 2018||Cape Town, Western Cape, South Africa|
|15 Jan 2018||Istanbul, Istanbul, Turkey|
|$45K||01 Jan 2018||Izmir, Izmir, Turkey|
Istanbul Startup Angels
|21 Dec 2017||Istanbul, Istanbul, Turkey|
|13 Dec 2017||Los Angeles, California, United States|
|30 Aug 2017||Izmir, Izmir, Turkey|
– Entos, Inc. (“Entos” or “the Company”), the creator of a cutting-edge platform combining AI-driven technology and automated synthetic development to design small-molecule therapeutics, announced the closing of a $53 million Series A.
– The financing round was led by Coatue, a leading technology investment firm, and Catalio Capital Management, a leading biomedical technology investment firm, with participation from OrbiMed and Sequoia Capital as well as existing investors Nexus Ventures and Freeflow.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.